CVS Health Co. (NYSE:CVS) Holdings Raised by IFP Advisors Inc

IFP Advisors Inc boosted its stake in CVS Health Co. (NYSE:CVS) by 91.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,413 shares of the pharmacy operator’s stock after buying an additional 10,222 shares during the period. IFP Advisors Inc’s holdings in CVS Health were worth $961,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. B&D White Capital Company LLC acquired a new stake in CVS Health in the fourth quarter worth approximately $417,000. Howard Capital Management Inc. raised its stake in shares of CVS Health by 13.6% in the 4th quarter. Howard Capital Management Inc. now owns 13,846 shares of the pharmacy operator’s stock worth $622,000 after buying an additional 1,653 shares in the last quarter. Wealthspire Advisors LLC lifted its holdings in shares of CVS Health by 10.1% in the fourth quarter. Wealthspire Advisors LLC now owns 15,962 shares of the pharmacy operator’s stock valued at $717,000 after buying an additional 1,468 shares during the period. Marshall Investment Management LLC bought a new position in CVS Health during the fourth quarter valued at about $166,000. Finally, TCW Group Inc. grew its holdings in CVS Health by 2.5% during the fourth quarter. TCW Group Inc. now owns 17,601 shares of the pharmacy operator’s stock worth $790,000 after acquiring an additional 435 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Buying and Selling at CVS Health

In related news, Director Michael F. Mahoney acquired 30,000 shares of the stock in a transaction dated Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.24% of the company’s stock.

CVS Health Stock Up 1.1 %

CVS opened at $64.54 on Friday. The company has a market capitalization of $81.37 billion, a PE ratio of 17.63, a price-to-earnings-growth ratio of 0.98 and a beta of 0.61. The business has a 50-day moving average of $53.90 and a 200-day moving average of $56.40. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Equities research analysts forecast that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.12%. The ex-dividend date was Thursday, January 23rd. CVS Health’s payout ratio is 72.68%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CVS shares. Cantor Fitzgerald upgraded shares of CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday, February 12th. Truist Financial lifted their target price on CVS Health from $60.00 to $76.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Wells Fargo & Company boosted their target price on CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. StockNews.com raised CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday, February 13th. Finally, TD Cowen upped their price objective on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $70.00.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.